• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.18% Nasdaq Down0.14%

    Transition Therapeutics Inc. (TTHI)

    -NasdaqGM
    2.25 Up 0.01(0.45%) 10:00AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2014Jun 30, 2013Jun 30, 2012
    Total Revenue -   16,999   -  
    Cost of Revenue -   -   -  
    Gross Profit -   16,999   -  
    Operating Expenses
    Research Development16,305  8,401  8,042  
    Selling General and Administrative4,611  3,372  4,323  
    Non Recurring -  6,205   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (20,916) (979) (12,489)
    Income from Continuing Operations
    Total Other Income/Expenses Net466  1,001  331  
    Earnings Before Interest And Taxes(20,450)22  (12,158)
    Interest Expense -   -  1  
    Income Before Tax(20,450)22  (12,159)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(20,450)22  (12,159)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (20,450) 22   (12,036)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (20,450) 22   (12,036)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.